524414 — Norris Medicines Balance Sheet
0.000.00%
- IN₹164.51m
- IN₹379.92m
- IN₹58.20m
Annual balance sheet for Norris Medicines, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 13.2 | 7.22 | 5.84 | 7.48 | 0.398 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17.9 | 10.9 | 11 | 10.6 | 14.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 82.3 | 42.7 | 49.2 | 61.4 | 63.4 |
| Net Property, Plant And Equipment | 76.7 | 70.7 | 64.7 | 57.9 | 52.7 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 198 | 142 | 137 | 142 | 138 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 117 | 67.8 | 77 | 92.3 | 101 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 272 | 249 | 261 | 278 | 287 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -74.3 | -107 | -124 | -136 | -149 |
| Total Liabilities & Shareholders' Equity | 198 | 142 | 137 | 142 | 138 |
| Total Common Shares Outstanding |